Related Experiment Video
Updated: Mar 10, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hemicrania Continua-Like Headache Related to Transdermal Nitroglycerine Therapy
Federico Mainardi1, Giorgio Zanchin2, Ferdinando Maggioni2
1Headache Centre, Neurological Division, SS Giovanni e Paolo Hospital, Venice, Italy.
Insights
This study reports a rare case of hemicrania continua (HC) triggered by transdermal nitroglycerine patch (TNP) use. Discontinuation of the TNP resolved the HC-like headache, highlighting a potential medication-induced headache.
Area of Science:
- Neurology
- Pharmacology
Background:
- Hemicrania continua (HC) is a rare, continuous, one-sided headache disorder.
- While several symptomatic cases of HC exist, medication-induced triggers are less commonly reported.
Observation:
- A 66-year-old male with a history of migraine without aura developed a new headache meeting HC criteria.
- The headache onset was directly linked to the use of a transdermal nitroglycerine patch (TNP).
Findings:
- Discontinuation of the TNP led to prompt resolution of the HC-like headache.
- Headache recurrence was observed upon reintroduction of nitroglycerine, confirming the causal link.
- The patient remained headache-free at one-year follow-up after permanent TNP cessation.
Implications:
- This case suggests that transdermal nitroglycerine patches can potentially induce hemicrania continua-like headaches.
- Clinicians should consider medication history, including transdermal patches, in the differential diagnosis of new-onset continuous headaches.
- Further research may be warranted to explore the mechanisms underlying nitroglycerine-induced headaches.
Abstract:
Several cases of symptomatic hemicrania continua (HC) have been reported. A 66-year-old man, suffering from migraine without aura, presented with a four month history of a new headache fulfilling the ICHD 3beta clinical criteria for HC. HC onset was strictly related to the use of transdermal nitroglycerine patch (TNP). In agreement with the cardiologist, TNP was discontinued and the headache promptly disappeared; symptoms reappeared within 6-12 hours after nitroglycerine reintroduction. After permanent discontinuation of TNP, headache disappeared at one year follow-up. To the best of our knowledge, this is the first report of the occurrence of an HC-like headache related to TNP.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Angina II: Classification
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Delivery: Enteral Route
Angina IV: Management

